Panacea Biotec touches roof on completing Phase 1/11 study to evaluate safety, immunogenicity of DengiAll

24 Sep 2020 Evaluate

Panacea Biotec is currently trading at its upper limit of Rs. 196.80, up by 9.35 points or 4.99% from its previous closing of Rs. 187.45 on the BSE.

The scrip opened at Rs. 186.95 and has touched a high and low of Rs. 196.80 and Rs. 182.00 respectively. So far 7588 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 253.53 on 12-Jun-2020 and a 52 week low of Rs. 86.76 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 215.41 and Rs. 182.00 respectively. The current market cap of the company is Rs. 1205.41 crore.

The promoters holding in the company stood at 73.59%, while Institutions and Non-Institutions held 1.28% and 25.13% respectively.

Panacea Biotec has successfully completed its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose live-attenuated tetravalent vaccine.

DengiAll has illustrated the strength of Panacea Biotec's expertise in vaccinology, research, development, and manufacturing while leveraging NIH's ability to work on complex biological challenges to develop breakthrough technologies. Panacea Biotec through continued support from National Institutes of Health, Technology Development Board, and other stakeholders is in a better position to increase affordable access to DengiAll to fight Dengue, a disease that has eluded mankind for generations. With more than 3.9 billion people living in Dengue endemic areas and over 390 million infections per year, DengiAll targets a global market of over $3 billion.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

556.05 19.00 (3.54%)
29-Apr-2025 09:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1835.85
Dr. Reddys Lab 1201.35
Cipla 1555.10
Lupin 2113.05
Zydus Lifesciences 893.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...